AIFA
-
News
List of innovative medicines: AIFA publishes the September 2022 update
L’AIFA aggiorna l’elenco dei medicinali che, a giudizio della Commissione Tecnico Scientifica (CTS), possiedono il requisito di innovatività terapeutica piena…
Leggi » -
First floor
Equalia. The AIFA Program for 2022 cuts the legs off the most accessible treatments
In the document sent by Health to the opinion of the State-Regions Conference the intention to renegotiate downward prices Egualia – 29…
Leggi » -
First floor
AIFA. 2022 activity plan: new guidelines for scientific information by 31 December
The activity plan for the year 2022 was presented at the State, Regions and Autonomous Provinces Conference, setting out the…
Leggi » -
News
EMA. Synchron Research Service: Review confirms suspension of generic medicines due to irregularities in studies
Il Comitato per i medicinali per uso umano (CHMP) dell’EMA ha confermato la propria raccomandazione di sospendere le autorizzazioni all’immissione…
Leggi » -
News
L’EMA raccomanda l’approvazione del vaccino adattato contro le varianti di Omicron BA.4 e BA.5 e il ceppo originario di SARS-CoV-2
Il comitato per i medicinali per uso umano (CHMP) dell’Agenzia europea per i medicinali (EMA) ha raccomandato l’autorizzazione di un…
Leggi » -
News
L’Agenzia europea per i medicinali ha avviato la procedura di approvazione subordinata a condizioni del vaccino anti-COVID-19 Skycovion
Il Comitato per i medicinali per uso umano (Committee for human medicinal products, CHMP) dell’Agenzia europea per i medicinali (EMA)…
Leggi » -
News
EFSA. Harmful titanium dioxide in foods and supplements, but not in drugs
Biossido di titanio: l’E171 non è più considerato sicuro se usato come additivo alimentare Comunicato EFSA L’EFSA ha aggiornato la…
Leggi » -
News
Trend of pharmaceutical expenditure supported by the National Health Service from 2019 to 2021
The analysis of the trend of pharmaceutical expenditure supported by the NHS shows a substantial stability of the expenditure paid by the NHS, which…
Leggi » -
Editorial notes
Garattini: There has been no use of antidepressants and the use that has taken place is due to the propaganda of pharmaceutical companies
An interview with Prof. Garattini (born in 1928) was published in the Bergamo News of August 3, who was asked…
Leggi » -
News
AIFA. Shelf of pharmaceutical expenditure for direct purchases for the year 2021 - Start of the procedure. Pharmaceutical companies will have to pay €1,034,700,865
AIFA, the Italian Medicines Agency, announces that the Board of Directors has acknowledged that the expenditure for direct purchases…
Leggi »